Medicare Enrolled

Dr. Vijay Babu Balakrishnan, M.D., CCD.

Endocrinology · Somers Point, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
18 W NEW YORK AVE, Somers Point, NJ 08244
6093655300
In practice since 2008 (18 years)
NPI: 1649434333 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Balakrishnan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Balakrishnan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Balakrishnan

Dr. Vijay Babu Balakrishnan is an endocrinology specialist in Somers Point, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Balakrishnan performed 1,454 Medicare services across 768 unique beneficiaries.

Between the years covered by Open Payments, Dr. Balakrishnan received a total of $6,071 from 48 pharmaceutical and/or device companies across 381 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Balakrishnan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 34% volume in NJ $6,071 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,454
Medicare services
Top 34% in NJ for endocrinology
768
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~81 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
894 $101 $230
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
246 $28 $61
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
84 $133 $299
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
76 $71 $200
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
67 $21 $200
Continuous glucose monitoring, sensor under skin
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment.
60 $116 $283
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
27 $94 $202
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,071
Total received (2018-2024)
Avg $867/year across 7 years
Top 25% in NJ for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
381
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,002 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$69 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,768
2023
$1,295
2022
$730
2021
$287
2020
$251
2019
$1,058
2018
$683

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$544
Novo Nordisk Inc
$279
Lilly USA, LLC
$152
SANOFI-AVENTIS U.S. LLC
$110
CeQur Corporation
$109
Bayer Healthcare Pharmaceuticals Inc.
$94
Merck Sharp & Dohme LLC
$85
Royal Biologics, Inc.
$77
Corcept Therapeutics
$65
Antares Pharma, Inc.
$58
Amgen Inc.
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
Xeris Pharmaceuticals, Inc.
$16
Verity Pharmaceuticals Inc.
$16
Tolmar, Inc.
$16
Medtronic, Inc.
$16
Kyowa Kirin, Inc.
$15
ABBVIE INC.
$14
Top 3 companies account for 55.2% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$1,285
Novo Nordisk Inc
$1,180
SANOFI-AVENTIS U.S. LLC
$673
Lilly USA, LLC
$337
Boehringer Ingelheim Pharmaceuticals, Inc.
$230
Janssen Pharmaceuticals, Inc
$215
AstraZeneca Pharmaceuticals LP
$205
Corcept Therapeutics
$162
Insulet Corporation
$131
CeQur Corporation
$127
Bayer Healthcare Pharmaceuticals Inc.
$118
MannKind Corporation
$105
Merck Sharp & Dohme Corporation
$99
United Therapeutics Corporation
$97
Merck Sharp & Dohme LLC
$85
Amgen Inc.
$79
Royal Biologics, Inc.
$77
Antares Pharma, Inc.
$71
Ortho Dermatologics, a division of Bausch Health US, LLC
$69
Medtronic, Inc.
$69
Mannkind Corporation
$56
Embecta Corp.
$54
Amneal Pharmaceuticals LLC
$51
Supernus Pharmaceuticals, Inc.
$48
Valeritas, Inc.
$32
Novartis Pharmaceuticals Corporation
$32
Kowa Pharmaceuticals America, Inc.
$29
Currax Pharmaceuticals LLC
$28
AbbVie, Inc.
$27
Becton, Dickinson and Company
$27
Bigfoot Biomedical Inc
$23
Tandem Diabetes Care, Inc.
$21
Ascensia Diabetes Care Us Inc.
$16
Xeris Pharmaceuticals, Inc.
$16
Verity Pharmaceuticals Inc.
$16
Tolmar, Inc.
$16
Medtronic MiniMed, Inc.
$16
Ascendis Pharma Inc
$16
Kyowa Kirin, Inc.
$15
Shire North American Group Inc
$15
ABBVIE INC.
$14
Radius Health, Inc.
$14
Dexcom, Inc.
$13
Alexion Pharmaceuticals, Inc.
$13
AbbVie Inc.
$13
Alfasigma USA, Inc.
$12
PFIZER INC.
$12
Orexigen Therapeutics, Inc.
$11
Top 3 companies account for 51.7% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ARAZLO · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · CONTRAVE · CeQur Simplicity · Crysvita · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · FreeStyle Libre Pro · GVOKE HYPOPEN · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LYRICA · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · NATPARA (PARATHYROID HORMONE) · NOCDURNA · Omnipod · Ozempic · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SYNTHROID · Saxenda · Sogroya · Strensiq · Synthroid · TLANDO · TOUJEO · TRULICITY · TYVASO · TZIELD · Tlando · Tresiba · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · Victoza · Wegovy · XARELTO · XYOSTED · iPro2 · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Somers Point?
Compare endocrinologists in the Somers Point area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
9
Per 100K population
3.3
County median income
$76,819
Nearest hospital
SHORE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Balakrishnan is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Balakrishnan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Balakrishnan performed 894 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Balakrishnan receive payments from pharmaceutical companies?
Yes. Dr. Balakrishnan received a total of $6,071 from 48 companies across 381 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Balakrishnan's costs compare to other endocrinologists in Somers Point?
Dr. Balakrishnan's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Balakrishnan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →